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Objectives: Neck radiation therapy (XRT) may induce carotid artery
atherosclerosis and may increase the technical difﬁculty of endarterectomy
(CEA). It is considered a relative indication for carotid angioplasty and
stenting (CAS). This study sought to evaluate differences in CAS embolic
potential and restenosis performed on XRT and non-XRT patients.
Methods: A total of 366 CAS procedures were performed on 321 pa-
tients (43 XRT and 323 non-XRT) at three institutions. Mean follow-up
was 410 days (median, 282 days; range, 3-1920 days). Patients were fol-
lowed up with duplex ultrasound imaging to assess for restenosis. Additional
end points included target lesion revascularization, myocardial and cerebro-
vascular events, and perioperative complications. Captured particulates from
embolic protection ﬁlters were analyzed using photomicroscopy and image
analysis software for 27 XRT and 214 non-XRT ﬁlters.
Results: XRT patient were more likely to be male and had lower rates
of hypertension, coronary artery disease, and diabetes mellitus, although the
mean age at procedure did not differ (Table). There was a trend toward
increased severe internal carotid tortuosity among XRT patients (XRT: 50%
vs non-XRT: 34.7%; P ¼ .05). Indication for CAS did not differ between
the two groups, including the number of CAS performed for symptomatic
carotid stenosis (XRT: 39.7% vs non-XRT: 39.0%; P ¼ not signiﬁcant
[NS]). Perioperative outcomes, including the composite of 30-day stroke/
myocardial infarction/mortality were not signiﬁcantly different (XRT: 2.6%
vs non-XRT: 3.9%; P ¼ NS.) There were no signiﬁcant differences in the
restenosis rate at the 50% (XRT: 9.4% vs non-XRT: 8.6%; P ¼ NS) or 70%
(XRT: 3.5% vs non-XRT: 8.6%; P ¼ NS) threshold. Filter particle analysis
revealed that ﬁlters from XRT patients had more numerous large particles
per ﬁlter and larger particles (Table). Target lesion revascularization did not
differ signiﬁcantly between the groups.
Conclusions: In contrast to earlier studies, this analysis reveals that
there are signiﬁcant differences in XRT and non-XRT patients undergoing
CAS in terms of medical comorbidities, anatomy, and embolic potential.
A decreased incidence of atherosclerotic risk factors was observed in XRT
patients, likely because XRT was the primary factor responsible for carotid
stenosis. Despite increased tortuosity and embolic particle size, CAS can
be performed safely with no increased morbidity, target lesion revasculariza-
tion, or restenosis in XRT patients.
Table. Demographics and particulate data (P values by c2 and t-test)
Variable XRT Non-XRT PMean age, years 68.9 71.1 NS
Male, No. (%) 34 (79) 183 (56.7) <.01
Hypertension, No. (%) 26 (63.4) 292 (90.6) <.0001
Coronary artery disease, No. (%) 15 (36.5) 192 (59.6) <.05
Diabetes mellitus, No. (%) 8 (19.5) 117 (36.3) <.05
Particulate data
Mean maximum particle size/ﬁlter, mm 1.4 0.74 <.05
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Objectives: An upper extremity (UE) systolic blood pressure (SBP)
differential has been reported to be a marker for systemic atherosclerosis.
However, the relationship between the degree of SBP differential and the
prevalence of cerebrovascular disease has not been speciﬁcally deﬁned.
The goal of this study was to analyze a large cohort of patients who under-
went vascular screening tests and to determine the relationship between an
UE SBP differential, clinical cerebrovascular disease, and carotid artery
stenosis.Methods: Of 3,696,778 patient screened, 241,959 did not have both
UE SBP recorded, and were excluded. The remaining subjects were charac-
terized as having no signiﬁcant SBP difference (<10 mm Hg differential),
mild (11-15 mm Hg), moderate (16-20 mm Hg), and severe ($20 mm
Hg) differences. Standard statistical analysis was performed.
Results: Of 3,454,819 subjects, 86.8% had no signiﬁcant UE SBP dif-
ferential, 9.1% (313,352) had a mild difference, 3.9% (134,278) had a mod-
erate difference, and 0.2% (7657) had a severe difference. Increasing degrees
of UE SBP differential were directly and signiﬁcantly associated with
increased age, tobacco use, hypertension, hypercholesterolemia, diabetes,
and obesity (P < .001). Increasing degrees of UE SBP differential were
directly and signiﬁcantly associated with a history of stroke and a history
of transient ischemic attack. Increasing degrees of UE SBP differential
were directly and signiﬁcantly associated with both moderate ($50%) and
severe ($80%) carotid artery stenosis (P < .001; Fig). In multivariate
analysis, an UE SBP difference of $15 mm Hg was an independent pre-
dictor of carotid artery stenosis (odds ratio, 1.3); a differential of >20 mm
Hg nearly quadrupled the risk of having signiﬁcant carotid artery disease
(odds ratio, 3.9).
Conclusions: Subjects with UE SBP differentials are more likely to
have traditional atherosclerotic risk factors. However, even after adjusting
for these risk factors, an UE SBP difference is an independent risk factor
for cerebrovascular disease. SBP differentials noted in the upper extremities
can be potentially used as an excellent screening marker for the presence of
extracranial cerebrovascular disease.
Fig. BP difference and incidence of cerebrovascular disease.
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Objectives: The purpose of the study was to assess predictors of long-
term disease progression and clinical outcomes after carotid endarterectomy
(CEA) in contemporary practice.
Methods: A consecutive cohort of CEAs between January 1, 2000,
and December 31, 2010, was retrospectively analyzed. End points were
restenosis $50% and $70%, contralateral carotid disease progression
(50%-69%, 70%-99%, or occlusion), and stroke. Survival analysis and Cox
regression models were used to assess the effect of baseline predictors.
Results: A total of 1782 CEAs (bilateral, 142; mean age, 71.4 6 9.3
years; 56.3% male; 35.4% symptomatic, 2.7% combined with coronary artery
bypass grafting) were performed during the study period with a mean clin-
ical follow-up of 54.8 months (range, 1-155 months). Periprocedural stroke
and death rates were 1.9% and 0.8%, respectively (stroke/death: overall,
2.6%; asymptomatic cohort, 1.8%). Freedom from restenosis and contralat-
eral carotid stenosis progression is shown in the Fig, both events attaining
higher rates of critical values ($70%) after 5 years. Thirty-one (20.4%)
restenosis were symptomatic (5 at $50%, 26 at $70%), and 40 (26.3%)
underwent reintervention. Restenosis was predicted by hypertension (HR,
2.06; P ¼ .031), female gender (HR, 1.54; P ¼ .012), and younger age
#65 years (HR, 1.64; P ¼ .009). Contralateral progression was predicted
by smoking (HR, 1.85; P ¼ .007) and renal insufﬁciency (HR, 2.40; P ¼
.001), resulting in carotid intervention in 27.1% of patients. No association
was shown with either closure technique (primary vs patch vs eversion) or
statins. Any stroke (118 events: 68 ipsilateral, 49 contralateral) rates at 5 and
10 years were 7.2% and 14.9%, respectively. Predictors were symptomatic
indication (HR, 1.51; P ¼ .033), renal insufﬁciency (HR, 1.58; P ¼ .046),
